These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623 [TBL] [Abstract][Full Text] [Related]
8. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer. Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J Front Immunol; 2019; 10():691. PubMed ID: 31001284 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients. Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270 [TBL] [Abstract][Full Text] [Related]
10. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. Zhang B; Wang Z; Wu L; Zhang M; Li W; Ding J; Zhu J; Wei H; Zhao K PLoS One; 2013; 8(2):e57114. PubMed ID: 23437326 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer. Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522 [TBL] [Abstract][Full Text] [Related]
12. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. Karakasheva TA; Dominguez GA; Hashimoto A; Lin EW; Chiu C; Sasser K; Lee JW; Beatty GL; Gabrilovich DI; Rustgi AK JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563330 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma. Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells. Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270 [TBL] [Abstract][Full Text] [Related]
15. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475 [TBL] [Abstract][Full Text] [Related]
16. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer. Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574 [TBL] [Abstract][Full Text] [Related]
17. Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma. Sun SH; Benner B; Savardekar H; Lapurga G; Good L; Abood D; Nagle E; Duggan M; Stiff A; DiVincenzo MJ; Suarez-Kelly LP; Campbell A; Yu L; Wesolowski R; Howard H; Shah H; Kendra K; Carson WE Front Immunol; 2021; 12():740890. PubMed ID: 34712230 [TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. Okano S; Abu-Elmagd K; Kish DD; Keslar K; Baldwin WM; Fairchild RL; Fujiki M; Khanna A; Osman M; Costa G; Fung J; Miller C; Kayashima H; Hashimoto K Am J Transplant; 2018 Oct; 18(10):2544-2558. PubMed ID: 29509288 [TBL] [Abstract][Full Text] [Related]
19. [Correlation analysis between the numbers of G-MDSCs and M-MDSCs in peripheral blood decrease and therapeutic effect in patients with colorectal cancer]. Wang Y; Xu L; Yun Z; Chu Y; Fa Z; Deng J; Zhang Y; Wu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):546-551. PubMed ID: 30236209 [TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients. Sasidharan Nair V; Saleh R; Toor SM; Alajez NM; Elkord E Front Oncol; 2020; 10():1530. PubMed ID: 32984004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]